Introduction

Partnering for a healthier future

As well as the ground-breaking work we do in our own laboratories, we work in partnership with bio companies, academic institutions, governments and other non-profit organisations, sharing skills, knowledge and resources to achieve a common goal: improved health.

Welcome to Partnering with AstraZeneca

Improving health is one of the toughest challenges facing society today. As a global pure-play biopharmaceutical company, AstraZeneca has a key contribution to make by providing innovative medicines for some of the world’s most serious diseases.

We have a well defined business development strategy which is focused on supplementing the discovery, development and commercialisation of innovative medicines in our core therapy areas and complementing our technology capabilities through partnerships.

Why partnering is important to us

Partnering is an important supporting pillar of the overall strategy to supplement and strengthen our core pipeline and our position as a scientific leader.

The philosophy that ‘health connects us all’ drives our collaborative culture and approximately 40% of our overall pipeline has been sourced through partnerships.

BIO 2013 show reel

Missing translation key: locale='en_US', key='astrazeneca/Video:NoFlashOrJavaScript'

Watch some of the highlights from AstraZeneca's attendance at the 2013 BIO Convention in Chicago, US.

What we offer partners

Our goal is to offer our partners world class capabilities to bring new medicines to the market with a biotech mindset which encompasses quick, flexible, and creative decision making.

Our partnering process

We are committed to working with our collaborators to create tailored partnerships that are structured to best achieve our mutual goals.

Our areas of interest

Our partnering areas of interest are predominantly focused on three core disease areas which include cardiovascular & metabolic disease, respiratory, inflammation & autoimmune disease, and oncology. We remain interested but more opportunistic in partnering in the areas of infection and neuroscience. In addition we are interested in actively seeking collaborations in personalised healthcare and biomarkers, and around innovative science and technology platforms.

Talk to us

If you would like to begin a discussion about partnering, we look forward to talking and starting the process

 

Download our brochure

Download your comprehensive guide to partnering with us.


Meet us at an event

Calendar iconView our full event calendar to see events we are attending.

View calendar



Our commitment to successful partnerships

AstraZeneca partnering facts